Not Yet RecruitingNot Applicable

Atherosclerotic Cardiovascular Risk in Childhood and Teen-age Onset Diabetes

China300 participantsStarted 2022-06-01

Plain-language summary

For children and adolescents with diabetes, the pathological process of atherosclerotic cardiovascular disease(ASCVD) can exist in early childhood and progress rapidly to subclinical ASCVD. This study intends to explore the models for the prediction of ASCVD risk in childhood and teen-age onset diabetes with different types.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Diagnosis of type 1 diabetes or type 2 diabetes
✓. Age of onset: \<18y
✓. Enrollment age: ≥18y
✓. Gender: male or female
✓. Diabetes duration ≥ 5 years

Exclusion criteria

✕. Specific types of diabetes
✕. Clinical diagnosis of diabetes is unknown, and it belongs to untyped diabetes
✕. Pregnancy or lactation
✕. Received glucocorticoids, immunosuppressants, non-glycemic biological agents, and cytotoxic drugs in the past 3 months; non-steroidal pain relievers or antibiotics used for more than 1 week continuously
✕. Onset of acute complications of diabetes in the past 3 months
✕. Major trauma and surgery history in the past 3 months

What they're measuring

Occurrence of Atherosclerotic Cardiovascular Disease(ASCVD) high risk rating

Timeframe: 5 years

Trial details

NCT IDNCT05294653

SponsorShanghai Jiao Tong University School of Medicine

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2027-01-01

Contact for this trial

Weiqiong Gu, PhD

64370045 weiqionggu@163.com

View on ClinicalTrials.gov More Atherosclerotic Cardiovascular Disease trials